Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

NCT07464587 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: TQC3721 Suspension for Inhalation

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.